Bench-to-bedside review: Sepsis - from the redox point of view

Critical Care

Volumn 15, Issue 5, 2011, Pages

  Andrades, Michael T ^a   Morina, Arian ^b   Spasić, Snežana ^c   Spasojević, Ivan ^b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIOXIDANT; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; AQUAPORIN 8; CASPASE 3; CASPASE 7; CASPASE 9; CYCLOOXYGENASE 2; CYTOCHROME C; DIETHYLDITHIOCARBAMIC ACID; EXTRACELLULAR SUPEROXIDE DISMUTASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; HYPERTENSIVE FACTOR; HYPOCHLOROUS ACID; I KAPPA B; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; PEROXY RADICAL; PEROXYNITRITE; PEROXYNITROUS ACID; SUPEROXIDE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; REACTIVE OXYGEN METABOLITE;

ANALGESIA; ANTIMICROBIAL THERAPY; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; DNA POLYMORPHISM; DOWN REGULATION; DRUG MEGADOSE; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; FLUID RESUSCITATION; HEMODYNAMIC MONITORING; HEMOLYSIS; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; LEUKOCYTE MIGRATION; MACROPHAGE; NEUTROPHIL; NITROSYLATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; RESPIRATORY BURST; REVIEW; SEDATION; SEPSIS; SEPTIC SHOCK; METABOLISM; MITOCHONDRION; MULTIPLE ORGAN FAILURE;

HUMANS; MITOCHONDRIA; MULTIPLE ORGAN FAILURE; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SEPSIS;

EID: 80054678294     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10334     Document Type: Review

References (130)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med 2001, 29:1303-1311. 10.1097/00003246-200107000-00002, 11445675.
2. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34:344-353. 10.1097/01.CCM.0000194725.48928.3A, 16424713.
3. Lever A, Mackenzie I. Sepsis: definition, epidemiology, and diagnosis. BMJ 2007, 335:879-883. 10.1136/bmj.39346.495880.AE, 2043413, 17962288.
4. Thomas L. Germs. N Engl J Med 1972, 287:553-555. 10.1056/NEJM197209142871109, 5050429.
5. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
6. Deitch EA. Animal models of sepsis and shock: a review and lessons learned. Shock 1998, 9:1-11. 10.1097/00024382-199801000-00001, 9734290.
7. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150. 10.1056/NEJMra021333, 12519925.
8. Russell JA. Management of sepsis. N Engl J Med 2006, 355:1699-1713. 10.1056/NEJMra043632, 17050894.
9. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet-Riffaud P, Bellissant E. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862-871. 10.1001/jama.288.7.862, 12186604.
10. Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 1997, 3:678-681. 10.1038/nm0697-678, 9176497.
11. O'Suilleabhain C, O'Sullivan ST, Kelly JL, Lederer J, Mannick JA, Rodrick ML. Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury. Surgery 1996, 120:290-296. 10.1016/S0039-6060(96)80300-X, 8751595.
12. Hotchkiss RS, Swanson PE, Cobb JP, Jacobson A, Buchman TG, Karl IE. Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. Crit Care Med 1997, 25:1298-1307. 10.1097/00003246-199708000-00015, 9267941.
13. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999, 27:1230-1251. 10.1097/00003246-199907000-00002, 10446814.
14. Solez K, Morel-Maroger L, Sraer JD. The morphology of "acute tubular necrosis" in man: analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine 1979, 58:362-376.
15. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999, 340:207-214. 10.1056/NEJM199901213400307, 9895401.
16. Dare AJ, Phillips ARJ, Hickey AJR, Mittal A, Loveday B, Thompson N, Windsor JA. A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome. Free Radic Biol Med 2009, 47:1517-1525. 10.1016/j.freeradbiomed.2009.08.019, 19715753.
17. Hayes MA, Timmins AC, Yau EH, Palazzo M, Watson D, Hinds CJ. Oxygen transport patterns in patients with sepsis syndrome or septic shock: influence of treatment and relationship to outcome. Crit Care Med 1997, 25:926-936. 10.1097/00003246-199706000-00007, 9201043.
18. Van der Meer TJ, Wang H, Fink MP. Endotoxemia causes ileal mucosal acidosis in the absence of mucosal hypoxia in a normodynamic porcine model of septic shock. Crit Care Med 1995, 23:1217-1226. 10.1097/00003246-199507000-00011, 7600830.
19. Fink MP. Cytopathic hypoxia: mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin 2001, 17:219-237. 10.1016/S0749-0704(05)70161-5, 11219231.
20. Galley HF. Bench-to-bedside review: targeting antioxidants to mitochondria in sepsis. Crit Care 2010, 14:230. 2945094, 20804578.
21. Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, Davies NA, Cooper CE, Singer M. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002, 360:219-223. 10.1016/S0140-6736(02)09459-X, 12133657.
22. Fredriksson K, Hammarqvist F, Strigard K, Hultenby K, Ljungqvist O, Wernerman J, Rooyackers O. Derangements in mitochondrial metabolism in intercostal and leg muscle of critically ill patients with sepsis induced multiple organ failure. Am J Physiol Endocrinol Metab 2006, 291:E1044-E1050. 10.1152/ajpendo.00218.2006, 16803854.
23. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine 2007, Oxford: Oxford University Press.
24. Andrades ME, Ritter C, Dal-Pizzol F. The role of free radicals in sepsis development. Front Biosci (Elite Ed) 2009, 1:277-287.
25. Berger MM, Chiolero RL. Antioxidant supplementation in sepsis and systemic inflammatory response syndrome. Crit Care Med 2007, 35:S584-S590. 10.1097/01.CCM.0000279189.81529.C4, 17713413.
26. Crimi E, Liguori A, Condorelli M, Cioffi M, Astuto M, Bontempo P, Pignalosa O, Vietri MT, Molinari AM, Sica V, Della Corte F, Napoli C. The beneficial effects of antioxidant supplementation in enteral feeding in critically ill patients: A prospective, randomized, double-blind, placebo-controlled trial. Anesth Analg 2004, 99:857-863. 10.1213/01.ANE.0000133144.60584.F6, 15333422.
27. Ritter C, Andrades ME, Frota Junior ML, Bonatto F, Pinho RA, Polydoro M, Klamt F, Pinheiro CT, Menna-Barreto SS, Moreira JC, Dal-Pizzol F. Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation. Intensive Care Med 2003, 29:1782-1789. 10.1007/s00134-003-1789-9, 12783160.
28. Gao XP, Standiford TJ, Rahman A, Newstead M, Holland SM, Dinauer MC, Liu QH, Malik AB. Role of NADPH oxidase in the mechanism of lung neutrophil sequestration and microvessel injury induced by Gram-negative sepsis: studies in p47phox-/- and gp91phox-/- mice. J Immunol 2002, 168:3974-3982.
29. Babior BM. NADPH oxidase. Curr Opin Immunol 2004, 16:42-47. 10.1016/j.coi.2003.12.001, 14734109.
30. Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK. Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Crit Care Med 1996, 24:1179-1183. 10.1097/00003246-199607000-00019, 8674332.
31. Pascual C, Karzai W, Meier-Hellmann A, Oberhoffer M, Horn A, Bredle D, Reinhart K. Total plasma antioxidant capacity is not always decreased in sepsis. Crit Care Med 1998, 26:705-709. 10.1097/00003246-199804000-00019, 9559608.
32. Cherian S, Jameson S, Rajarajeswari C, Helena V, Latha L, Rekha A, Nagamma T, Raju S, Kini PG, Rao A. Oxidative stress in sepsis in children. Indian J Med Res 2007, 125:143-148.
33. Edmond K, Zaidi A. New approaches to preventing, diagnosing, and treating neonatal sepsis. PLoS Med 2010, 7:e1000213. 10.1371/journal.pmed.1000213, 2834705, 20231868.
34. Baltimore RS. Neonatal sepsis: epidemiology and management. Paediatr Drugs 2003, 5:723-740. 10.2165/00148581-200305110-00002, 14580222.
35. Winterbourn CC. Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid. Toxicology 2002, 181:223-227.
36. Adibhatla RM, Hatcher JF. Lipid oxidation and peroxidation in CNS health and disease: From molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2010, 12:125-169. 10.1089/ars.2009.2668, 19624272.
37. Rees MD, Whitelock JM, Malle E, Chuang CY, Iozzo RV, Nilasaroya A, Davies MJ. Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan. Matrix Biol 2010, 29:63-73. 10.1016/j.matbio.2009.09.005, 2818291, 19788922.
38. Park SY, Shin SW, Lee S, Park J. Hypochlorous acid-induced modulation of cellular redox status in HeLa cells. Arch Pharm Res 2008, 31:905-910. 10.1007/s12272-001-1245-y, 18704334.
39. D'Autreaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007, 8:813-824. 10.1038/nrm2256, 17848967.
40. Macdonald J, Galley HF, Webster NR. Oxidative stress and gene expression in sepsis. Br J Anaesth 2003, 90:221-232. 10.1093/bja/aeg034, 12538380.
41. Hur W, Gray NS. Small molecule modulators of antioxidant response pathway. Curr Opin Chem Biol 2011, 15:162-173. 10.1016/j.cbpa.2010.12.009, 21195017.
42. Jung KA, Kwak MK. The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules 2010, 15:7266-7291. 10.3390/molecules15107266, 20966874.
43. Thimmulappa RK, Lee H, Rangasamy T, Reddy SP, Yamamoto M, Kensler TW, Biswal S. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest 2006, 116:984-995. 10.1172/JCI25790, 1421348, 16585964.
44. Kong X, Thimmulappa R, Kombairaju P, Biswal S. NADPH oxidase-dependent reactive oxygen species mediate amplified TLR4 signaling and sepsisinduced mortality in Nrf2-deficient mice. J Immunol 2010, 185:569-577. 10.4049/jimmunol.0902315, 2913313, 20511556.
45. Deng Z, Pardi R, Cheadle W, Xiang X, Zhang S, Shah SV, Grizzle W, Miller D, Mountz J, Zhang HG. Plant homologue constitutive photomorphogenesis 9 (COP9) signalosome subunit CSN5 regulates innate immune responses in macrophages. Blood 2011, 117:4796-4804. 10.1182/blood-2010-10-314526, 21403132.
46. Barnes PJ. Nuclear factor-κB. Int J Biochem Cell Biol 1997, 29:867-870. 10.1016/S1357-2725(96)00159-8, 9304801.
47. Blackwell TS, Yull FE, Chen C-L, Venkatakrishnan A, Blackwell TR, Hicks DJ, Lancaster LH, Christman JW, Kerr LD. Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation. Am J Respir Crit Care Med 2000, 162:1095-1101.
48. Arnalich F, Garcia-Palomero E, López J, Jiménez M, Madero R, Renart J, Vázquez JJ, Montiel C. Predictive value of nuclear factor kB activity and plasma cytokine levels in patients with sepsis. Infect Immun 2000, 68:1942-1945. 10.1128/IAI.68.4.1942-1945.2000, 97370, 10722586.
49. Böhrer H, Qiu F, Zimmermann T, Zhang Y, Jllmer T, Männel D, Böttiger BW, Stern DM, Waldherr R, Saeger HD, Ziegler R, Bierhaus A, Martin E, Nawroth PP. Role of NF-kB in the mortality of sepsis. J Clin Invest 1997, 100:972-985. 10.1172/JCI119648, 508272, 9276714.
50. Bernard GR, Vincent JL, Laterre PF, La Rosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ. Efficacy and safety of recombinant human activated protein c for severe sepsis. N Engl J Med 2001, 344:699-709. 10.1056/NEJM200103083441001, 11236773.
51. Nam NH. Naturally occurring NF-kappaB inhibitors. Mini Rev Med Chem 2006, 6:945-951. 10.2174/138955706777934937, 16918500.
52. Virdis A, Colucci R, Fornai M, Blandizzi C, Duranti E, Pinto S, Bernardini N, Segnani C, Antonioli L, Taddei S, Salvetti A, Del Tacca M. Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: Role of inducible nitric-oxide synthase and oxidative stress. J Pharmacol Exp Ther 2005, 312:945-953.
53. Wartenberg M, Hoffmann E, Schwindt H, Grunheck F, Petros J, Arnold JR, Hescheler J, Sauer H. Reactive oxygen species-linked regulation of the multidrug resistance transporter P-glycoprotein in Nox-1 overexpressing prostate tumor spheroids. FEBS Lett 2005, 579:4541-4549. 10.1016/j.febslet.2005.06.078, 16083877.
54. Lange M, Connelly R, Traber DL, Hamahata A, Nakano Y, Esechie A, Jonkam C, von Borzyskowski S, Traber LD, Schmalstieg FC, Herndon DN, Enkhbaatar P. Time course of nitric oxide synthases, nitrosative stress, and poly(ADP ribosylation) in an ovine sepsis model. Crit Care 2010, 14:R129. 10.1186/cc9097, 2945093, 20602787.
55. Moncada S, Palmer R, Higgs E. Nitric oxide-physiology, pathophysiology, and pharmacology. Pharm Rev 1991, 43:109-142.
56. Belcher E, Mitchell J, Evans T. Myocardial dysfunction in sepsis: no role for NO?. Heart 2002, 87:507-509. 10.1136/heart.87.6.507, 1767140, 12010927.
57. Bruins MJ, Lamers WH, Meijer AJ, Soeters PB, Deutz NE. In vivo measurement of nitric oxide production in porcine gut, liver and muscle during hyperdynamic endotoxaemia. Br J Pharmacol 2002, 137:1225-1236. 10.1038/sj.bjp.0704993, 1573617, 12466232.
58. Nicholson SC, Hahn RT, Grobmyer SR, Brause JE, Hafner A, Potter S, Devereux RB, Nathan CF. Echocardiographic and survival studies in mice undergoing endotoxic shock: effects of genetic ablation of inducible nitric oxide synthase and pharmacologic antagonism of platelet-activating factor. J Surg Res 1999, 86:198-205. 10.1006/jsre.1999.5715, 10534424.
59. Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller W, Moncada S, Liew FY. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995, 375:408-411. 10.1038/375408a0, 7539113.
60. Yin GQ, Du KH, Gu FR, Fang ZX, Tang JQ, Zhong B, Zhu XY, Wu YW, Lu CP. Early-phase endotoxic shock-induced myocardial injury increases iNOS and selectin expression in macaque primate. Heart Lung Circ 2007, 16:85-92. 10.1016/j.hlc.2006.10.006, 17314070.
61. Sato K, Miyakawa K, Takeya M, Hattori R, Yui Y, Sunamoto M, Ichimori Y, Ushio Y, Takahashi K. Immunohistochemical expression of inducible nitric oxide synthase (iNOS) in reversible endotoxic shock studied by a novel monoclonal antibody against rat iNOS. J Leukoc Biol 1995, 57:36-44.
62. Evans T, Carpenter A, Kinderman H, Cohen J. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993, 41:77-81.
63. Vincent JL. Metabolic support in sepsis and multiple organ failure: more questions than answers. Crit Care Med 2007, 35:S436-S440. 10.1097/01.CCM.0000278601.93369.72, 17713390.
64. Umbreit J. Methemoglobin - it's not just blue: a concise review. Am J Hematol 2007, 82:134-144. 10.1002/ajh.20738, 16986127.
65. Zavodnik LB, Zavodnik IB, Lapshyna EA, Buko VU, Bryszewska MJ. Hypochlorous acid-induced membrane pore formation in red blood cells. Bioelectrochemistry 2002, 58:157-161. 10.1016/S1567-5394(02)00151-2, 12414321.
66. Schuerholz T, Irmer J, Simon TP, Reinhart K, Marx G. Methemoglobin level as an indicator for disease severity in sepsis. Crit Care 2008, 12(Suppl 2):P448.
67. Bullen J, Griffiths E, Rogers H, Ward G. Sepsis: the critical role of iron. Microbes Infect 2000, 2:409-415. 10.1016/S1286-4579(00)00326-9, 10817643.
68. Liu X, Spolarics Z. Methemoglobin is a potent activator of endothelial cells by stimulating IL-6 and IL-8 production and E-selectin membrane expression. Am J Physiol Cell Physiol 2003, 285:C1036-C1046.
69. Wu F, Schuster DP, Tyml K, Wilson JX. Ascorbate inhibits NADPH oxidase subunit p47phox expression in microvascular endothelial cells. Free Radic Biol Med 2007, 42:124-131. 10.1016/j.freeradbiomed.2006.10.033, 17157199.
70. Jacobi J, Kristal B, Chezar J, Shaul SM, Sela S. Exogenous superoxide mediates pro-oxidative, proinflammatory, and procoagulatory changes in primary endothelial cell cultures. Free Radic Biol Med 2005, 39:1238-1248. 10.1016/j.freeradbiomed.2005.06.010, 16214039.
71. Hocherl K, Dreher F, Kurtz A, Bucher M. Cyclooxygenase-2 inhibition attenuates lipopolysaccharide-induced cardiovascular failure. Hypertension 2002, 40:947-953. 10.1161/01.HYP.0000041221.13644.B9, 12468584.
72. Devrim E, Avci A, Erguder IB, Karagenc N, Kulah B, Durak I. Activities of xanthine oxidase and superoxide dismutase enzymes in rat intestinal tissues in sepsis. J Trauma 2008, 64:733-735. 10.1097/01.ta.0000242214.04800.48, 18332815.
73. Luchtemberg MN, Petronilho F, Constantino L, Gelain DP, Andrades M, Ritter C, Moreira JC, Streck EL, Dal-Pizzol F. Xanthine oxidase activity in patients with sepsis. Clin Biochem 2008, 41:1186-1190. 10.1016/j.clinbiochem.2008.07.015, 18775690.
74. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 2009, 417:1-13. 10.1042/BJ20081386, 2605959, 19061483.
75. Davies NA, Cooper CE, Stidwell R, Singer M. Inhibition of mitochondrial respiration during early stage sepsis. Adv Exp Med Biol 2003, 530:725-736. 10.1007/978-1-4615-0075-9_73, 14562771.
76. Boulos M, Astiz ME, Barua RS, Osman M. Impaired mitochondrial function induced by serum from septic shock patients is attenuated by inhibition of nitric oxide synthase and poly (ADP-ribose) synthase. Crit Care Med 2003, 31:353-358. 10.1097/01.CCM.0000050074.82486.B2, 12576936.
77. Sjóvall F, Morota S, Hansson MJ, Friberg H, Gnaiger E, Elmér E. Temporal increase of platelet mitochondrial respiration is negatively associated with clinical outcome in patients with sepsis. Crit Care 2010, 14:R214. 10.1186/cc9337, 21106065.
78. Hare JM. Nitroso-redox balance in the cardiovascular system. N Engl J Med 2004, 351:2112-2114. 10.1056/NEJMe048269, 15533853.
79. Li JM, Shah AM. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 2004, 287:R1014-1030. 10.1152/ajpregu.00124.2004, 15475499.
80. Angstwurm MWA, Schottdorf J, Schopohl J, Gaertner R. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med 1999, 27:1807-1813. 10.1097/00003246-199909000-00017, 10507602.
81. Szabó C, Cuzzocrea S, Zingarelli B, O'Connor M, Salzman AL. Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J Clin Invest 1997, 100:723-735. 10.1172/JCI119585, 508242, 9239421.
82. Soriano FG, Liaudet L, Szabo E, Virág L, Mabley JG, Pacher P, Szabó C. Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice. Shock 2002, 17:286-292. 10.1097/00024382-200204000-00008, 11954828.
83. Goldfarb RD, Marton A, Szabó E, Virag L, Salzman AL, Glock D, Akhter I, McCarthy R, Parrillo JE, Szabó C. Protective effect of a novel, potent inhibitor of poly(adenosine 5'-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis. Crit Care Med 2002, 30:974-980. 10.1097/00003246-200205000-00004, 12006790.
84. Khan AU, Delude RL, Han YY, Sappington PL, Han X, Carcillo JA, Fink MP. Liposomal NAD+ prevents diminished O2 consumption by immunostimulated Caco-2 cells. Am J Physiol Lung Cell Mol Physiol 2002, 282:L1082-L1091.
85. Lush CW, Cepinskas G, Kvietys PR. Regulation of intestinal nuclear factorkappaB activity and E-selectin expression during sepsis: a role for peroxynitrite. Gastroenterology 2003, 124:118-128. 10.1053/gast.2003.50001, 12512036.
86. Crouser ED, Julian MW, Blaho DV, Pfeiffer DR. Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity. Crit Care Med 2002, 30:276-284. 10.1097/00003246-200202000-00002, 11889292.
87. Zapelini PH, Rezin GT, Cardoso MR, Ritter C, Klamt F, Moreira JC, Streck EL, Dal-Pizzol F. Antioxidant treatment reverses mitochondrial dysfunction in a sepsis animal model. Mitochondrion 2008, 8:211-218. 10.1016/j.mito.2008.03.002, 18417427.
88. Bienert GP, Moller ALB, Kristiansen KA, Schulz A, Møller IM, Schjoerring JK, Jahn TP. Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes. J Biol Chem 2007, 282:1183-1192.
89. Lehmann GL, Carreras FI, Soria LR, Gradilone SA, Marinelli RA. LPS induces the TNF-α-mediated downregulation of rat liver aquaporin-8: role in sepsisassociated cholestasis. Am J Physiol Gastrointest Liver Physiol 2008, 294:G567-G575.
90. Sørensen TIA, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988, 318:727-732. 10.1056/NEJM198803243181202, 3347221.
91. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Intensive Care Med 2008, 34:17-60. 10.1007/s00134-007-0934-2, 2249616, 18058085.
92. Mishra V. Oxidative stress and role of antioxidant supplementation in critical illness. Clin Lab 2007, 53:199-209.
93. Buras JA, Holzmann B, Sitkovsky M. Animal models of sepsis: setting the stage. Nat Rev Drug Discov 2005, 4:854-865. 10.1038/nrd1854, 16224456.
94. Rittirsch D, Hoesel LM, Ward PA. The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol 2007, 81:137-143.
95. Zanotti-Cavazzoni SL, Goldfarb RD. Animal models of sepsis. Crit Care Clin 2009, 25:703-719. 10.1016/j.ccc.2009.08.005, 19892248.
96. Kohen R, Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 2002, 30:620-650. 10.1080/01926230290166724, 12512863.
97. Lane N. A unifying view of aging and disease: the double-agent theory. J Theor Biol 2003, 225:531-540. 10.1016/S0022-5193(03)00304-7, 14615212.
98. Spasojević I, Bajić A, Jovanović K, Spasić M, Andjus P. Protective role of fructose in the metabolism of astroglial C6 cells exposed to hydrogen peroxide. Carbohydr Res 2009, 344:1676-1681. 10.1016/j.carres.2009.05.023, 19591975.
99. Fink MP. Ethyl pyruvate: a novel treatment for sepsis. Curr Drug Targets 2007, 8:515-518. 10.2174/138945007780362791, 17430122.
100. Yin H, Jin X, Gong Q, Yang H, Hu LY, Gong F, Zhu J. Fructose-1,6-diphosphate attenuates acute lung injury induced by lipopolysaccharide in mice. Int Immunopharmacol 2008, 8:1842-1847. 10.1016/j.intimp.2008.09.004, 18824250.
101. Nunes FB, Simoes Pires MG, Farias Alves Filho JC, Wäschter PH, Rodrigues De Oliveira J. Physiopathological studies in septic rats and the use of fructose 1,6-bisphosphate as cellular protection. Crit Care Med 2002, 30:2069-2074. 10.1097/00003246-200209000-00020, 12352043.
102. de Mello RO, Lunardelli A, Caberlon E, de Moraes CM, Christ Vianna Santos R, da Costa VL, da Silva GV, da Silva Scherer P, Buaes LE, da Silva Melo DA, Donadio MV, Nunes FB, de Oliveira JR. Effect of N-acetylcysteine and fructose-1,6-bisphosphate in the treatment of experimental sepsis. Inflammation 2010 [Epub ahead of print],
103. Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, Yang R, Czura CJ, Fink MP, Tracey KJ. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci USA 2002, 99:12351-12356. 10.1073/pnas.192222999, 129448, 12209006.
104. Xie K, Yu Y, Pei Y, Hou L, Chen S, Xiong L, Wang G. Protective effects of hydrogen gas on murine polymicrobial sepsis via reducing oxidative stress and hmgb1 release. Shock 2010, 34:90-97.
105. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003, 31:359-366. 10.1097/01.CCM.0000045568.12881.10, 12576937.
106. Ferreira F, Ladriére L, Vincent JL, Malaisse WJ. Prolongation of survival time by infusion of succinic acid dimethyl ester in a caecal ligation and perforation model of sepsis. Horm Metab Res 2000, 32:335-336. 10.1055/s-2007-978647, 10983631.
107. Protti A, Carré J, Frost MT, Taylor V, Stidwill R, Rudiger A, Singer M. Succinate recovers mitochondrial oxygen consumption in septic rat skeletal muscle. Crit Care Med 2007, 35:2150-2156. 10.1097/01.ccm.0000281448.00095.4d, 17855829.
108. Erl W, Weber C, Wardemann C, Weber PC. Alpha-tocopheryl succinate inhibits monocytic cell adhesion to endothelial cells by suppressing NF-kappa B mobilization. Am J Physiol 1997, 273:H634-H640.
109. King C, Tytgat S, Delude RL, Fink MP. Ileal mucosal oxygen consumption is decreased in endotoxaemic rats but is restored toward normal by treatment with aminoguanidine. Crit Care Med 1999, 27:2518-2524. 10.1097/00003246-199911000-00032, 10579274.
110. Unno N, Wang H, Menconi MJ, Tytgat SH, Larkin V, Smith M, Morin MJ, Chavez A, Hodin RA, Fink MP. Inhibition of nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology 1997, 113:1246-1257. 10.1053/gast.1997.v113.pm9322519, 9322519.
111. Nin N, Cassina A, Boggia J, Alfonso E, Botti H, Peluffo G, Trostchansky A, Batthyány C, Radi R, Rubbo H, Hurtado FJ. Septic diaphragmatic dysfunction is prevented by Mn(III)porphyrin therapy and inducible nitric oxide synthase inhibition. Intensive Care Med 2004, 30:2271-2278. 10.1007/s00134-004-2427-x, 15349724.
112. Callahan L, Stofan DA, Szweda LI, Nethery DE, Supinski GS. Free radicals alter maximal diaphragmatic mitochondrial oxygen consumption in endotoxin-induced sepsis. Free Radic Biol Med 2001, 30:129-138. 10.1016/S0891-5849(00)00454-8, 11134903.
113. Matejović M, Krouzecky A, Martinkova V, Rokyta R, Kralova H, Treska V, Radermacher P, Novak I. Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia. Shock 2004, 21:458-465. 10.1097/00024382-200405000-00010, 15087823.
114. Wang W, Mitra A, Poole B, Falk S, Lucia MS, Tayal S, Schrier R. Endothelial nitric oxide synthase-deficient mice exhibit increased susceptibility to endotoxin-induced acute renal failure. Am J Physiol Renal Physiol 2004, 287:F:1044-1048. 10.1152/ajprenal.00136.2004, 15475535.
115. Komarov AM, Mak IT, Weglicki WB. Iron potentiates nitric oxide scavenging by dithiocarbamates in tissue of septic shock mice. Biochim Biophys Acta 1997, 1361:229-234.
116. Galley HF, Davies MJ, Webster NR. Ascorbyl radical formation in patients with sepsis: effects of ascorbate loading. Free Radic Biol Med 1996, 20:139-143. 10.1016/0891-5849(95)02022-5, 8903690.
117. Long CL, Maull KI, Krishnan RS, Laws HL, Geiger JW, Borghesi L, Franks W, Lawson TC, Sauberlich HE. Ascorbic acid dynamics in the seriously ill and injured. J Surg Res 2003, 109:144-148. 10.1016/S0022-4804(02)00083-5, 12643856.
118. Goode HF, Cowley HC, Walker BE, Howdle PD, Webster NR. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 1995, 23:646-651. 10.1097/00003246-199504000-00011, 7712754.
119. Quinlan GJ, Margarson MP, Mumby S, Evans TW, Gutteridge JMC. Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci 1998, 95:459-465. 10.1042/CS19980191, 9748422.
120. Galley HF, Webster NR. Elevated serum bleomycin-detectable iron concentrations in patients with sepsis syndrome. Intensive Care Med 1996, 22:226-229. 10.1007/BF01712241, 8727436.
121. Abiles J, Peréz de la Cruz A, Castaño J, Rodríguez-Elvira M, Aguayo E, Moreno-Torres R, Llopis J, Aranda P, Argüelles S, Ayala A, Machado de la Quintana A, Planells EM. Oxidative stress is increased in critically ill patients according to antioxidant vitamins intake, independent of severity: a cohort study. Crit Care 2006, 10:R146. 10.1186/cc5068, 1751071, 17040563.
122. Hotchkiss RS, Morikawa S, Inubushi T, Takahashi K, Ishii H, Ozawa K. Gluconeogenesis and phosphoenergetics in rat liver during endotoxemia. J Surg Res 1998, 74:179-186. 10.1006/jsre.1997.5253, 9587358.
123. Perianayagam MC, Liangos O, Kolyada AY, Wald R, MacKinnon RW, Li L, Rao M, Balakrishnan VS, Bonventre JV, Pereira BJ, Jaber BL. NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol 2007, 18:255-263. 10.1681/ASN.2006070806, 17151330.
124. Elsakka NE, Webster NR, Galley HF. Polymorphism in the manganese superoxide dismutase gene. Free Radic Res 2007, 41:770-778. 10.1080/10715760701338828, 17577737.
125. Huttunen R, Hurme M, Laine J, Eklund C, Vuento R, Aittoniemi J, Huhtala H, Syrjänen J. Endothelial nitric oxide synthase G894T (GLU298ASP) polymorphism is associated with hypotension in patients with E. coli bacteremia but not in bacteremia caused by a gram-positive organism. Shock 2009, 31:448-453. 10.1097/SHK.0b013e318188e58e, 18827745.
126. Molle I, Ostergaard M, Melsvik D, Nyvold CG. Infectious complications after chemotherapy and stem cell transplantation in multiple myeloma: implications of Fc gamma receptor and myeloperoxidase promoter polymorphisms. Leuk Lymphoma 2008, 49:1116-1122. 10.1080/10428190802074585, 18452102.
127. Marzec JM, Christie JD, Reddy SP, Jedlicka AE, Vuong H, Lanken PN, Aplenc R, Yamamoto T, Yamamoto M, Cho HY, Kleeberger SR. Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. FASEB J 2007, 21:2237-2246. 10.1096/fj.06-7759com, 17384144.
128. Sheu CC, Zhai R, Wang Z, Gong MN, Tejera P, Chen F, Su L, Thompson BT, Christiani DC. Heme oxygenase-1 microsatellite polymorphism and haplotypes are associated with the development of acute respiratory distress syndrome. Intensive Care Med 2009, 35:1343-1351. 10.1007/s00134-009-1504-6, 2758618, 19526221.
129. Tang GJ, Huang SL, Yien HW, Chen WS, Chi CW, Wu CW, Lui WY, Chiu JH, Lee TY. Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 2000, 28:2733-2736. 10.1097/00003246-200008000-00008, 10966243.
130. Kolyada AY, Tighiouart H, Perianayagam MC, Liangos O, Madias NE, Jaber BL. A genetic variant of hypoxia-inducible factor-1alpha is associated with adverse outcomes in acute kidney injury. Kidney Int 2009, 75:1322-1329. 10.1038/ki.2009.68, 2872511, 19279559.